Antimicrobial Activity of Lactococcus Lactis Subsp. Lactis Isolated
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
The Influence of Probiotics on the Firmicutes/Bacteroidetes Ratio In
microorganisms Review The Influence of Probiotics on the Firmicutes/Bacteroidetes Ratio in the Treatment of Obesity and Inflammatory Bowel disease Spase Stojanov 1,2, Aleš Berlec 1,2 and Borut Štrukelj 1,2,* 1 Faculty of Pharmacy, University of Ljubljana, SI-1000 Ljubljana, Slovenia; [email protected] (S.S.); [email protected] (A.B.) 2 Department of Biotechnology, Jožef Stefan Institute, SI-1000 Ljubljana, Slovenia * Correspondence: borut.strukelj@ffa.uni-lj.si Received: 16 September 2020; Accepted: 31 October 2020; Published: 1 November 2020 Abstract: The two most important bacterial phyla in the gastrointestinal tract, Firmicutes and Bacteroidetes, have gained much attention in recent years. The Firmicutes/Bacteroidetes (F/B) ratio is widely accepted to have an important influence in maintaining normal intestinal homeostasis. Increased or decreased F/B ratio is regarded as dysbiosis, whereby the former is usually observed with obesity, and the latter with inflammatory bowel disease (IBD). Probiotics as live microorganisms can confer health benefits to the host when administered in adequate amounts. There is considerable evidence of their nutritional and immunosuppressive properties including reports that elucidate the association of probiotics with the F/B ratio, obesity, and IBD. Orally administered probiotics can contribute to the restoration of dysbiotic microbiota and to the prevention of obesity or IBD. However, as the effects of different probiotics on the F/B ratio differ, selecting the appropriate species or mixture is crucial. The most commonly tested probiotics for modifying the F/B ratio and treating obesity and IBD are from the genus Lactobacillus. In this paper, we review the effects of probiotics on the F/B ratio that lead to weight loss or immunosuppression. -
Administration of L. Salivarius Expressing 3D8 Scfv As a Feed Additive Improved the Growth Performance, Immune Homeostasis, and Gut Microbiota of Chickens
Received: 22 January 2020 | Revised: 2 April 2020 | Accepted: 24 April 2020 DOI: 10.1111/asj.13399 ORIGINAL ARTICLE Administration of L. salivarius expressing 3D8 scFv as a feed additive improved the growth performance, immune homeostasis, and gut microbiota of chickens Shanmugam Sureshkumar1,2 | Sun Keun Jung1 | Dongjun Kim3 | Keon Bong Oh1 | Hyeon Yang1 | Hwi Cheul Lee1 | Yong Jin Jo1 | Hae Sun Lee1 | Sukchan Lee3 | Sung June Byun1 1Animal Biotechnology Division, National Institute of Animal Science, Rural Abstract Development Administration, Wanju-gun, Probiotics have been defined as live microorganisms that are administered in an ap- Republic of Korea propriate amount to provide health benefits to the host animal. In this study, we in- 2Department of Animal Resource and Science, Dankook University, Cheonan, vestigated the effect of L. salivarius DJ-sa-01 secreting the 3D8 single-chain variable Republic of Korea fragment (3D8 scFv) on the growth performance, cytokine secretion, and intestinal 3Department of Integrative Biotechnology, Sungkyunkwan University, Gyeonggi-do, microbial flora of chickens. The experiment was divided into the control group and Republic of Korea L. salivarius expressing 3D8 scFv experimental group. Chicken was fed 109 colony- Correspondence forming units (CFUs) of wild-type (WT) L. salivarius or 3D8 scFv-secreting L. salivarius Sung June Byun, Animal Biotechnology daily for 35 days. The administration of L. salivarius expressing 3D8 scFv signifi- Division, National Institute of Animal Science, Rural Development Administration, cantly improved the body weight of chickens compared with the administration of 1500, Wanju-gun, 441-706, Republic of WT L. salivarius. A 16S ribosomal RNA metagenomic analysis showed that Firmicutes, Korea. -
Guide to Probiotics
Department of Nutrition and Dietetics 01935 384250 Guide to Probiotics If you would like this leaflet in another format or in a different language, please contact the hospital’s communications Department of Nutrition department on 01935 384233 or email and Dietetics— 01935 384250 [email protected] Leaflet No: 88061014 Date: 12/14 Review by: 12/16 www.yeovilhospital.nhs.uk Bio-Kult Bacillus subtilis Minimum 2 Tablet Online Bifidobacterium bifidum billion live www.bio-kult.com Bifidobacterium breve microorganisms Bifidobacterium infantis per capsule Also available in some Bifidobacterium longum shops. Lactobacillus acidophilus L.delbrueckii ssp. Bulgaricus L. casei L. plantarum L. rhamnosus L. Helveticus L. Salivarius Lactococcus lactis ssp. Lactis Streptococcus thermophiles Biogaia Lactobacillus reu- Minimum 200 Lozenge Online teri Protectis million live www.biogaia.co.uk bacteria in 1 lozenge Recommended use: Please note that some patients experience a slight increase in their symptoms in the first week of us- ing a high dose probiotic. Just bear with it but if you are concerned, please contact us. Introduction The human gut contains millions of bacteria living in balance with each other. This balance can be upset for various reasons including antibiotic use or following an upset stomach when certain bacteria grow in higher numbers than usual. What are probiotics? Available Available from Hollandand Barrett Online www.symprove.com Or via telephone 01252 413600 Available from Probiotics are live bacteria often referred to as ‘good’ or ‘friendly’ bacteria, which may have health benefits by improving the balance of our gut bacteria. They may help if suffering with wind, bloating or constipation or if affected by antibiotic associated bacteria. -
A Taxonomic Note on the Genus Lactobacillus
Taxonomic Description template 1 A taxonomic note on the genus Lactobacillus: 2 Description of 23 novel genera, emended description 3 of the genus Lactobacillus Beijerinck 1901, and union 4 of Lactobacillaceae and Leuconostocaceae 5 Jinshui Zheng1, $, Stijn Wittouck2, $, Elisa Salvetti3, $, Charles M.A.P. Franz4, Hugh M.B. Harris5, Paola 6 Mattarelli6, Paul W. O’Toole5, Bruno Pot7, Peter Vandamme8, Jens Walter9, 10, Koichi Watanabe11, 12, 7 Sander Wuyts2, Giovanna E. Felis3, #*, Michael G. Gänzle9, 13#*, Sarah Lebeer2 # 8 '© [Jinshui Zheng, Stijn Wittouck, Elisa Salvetti, Charles M.A.P. Franz, Hugh M.B. Harris, Paola 9 Mattarelli, Paul W. O’Toole, Bruno Pot, Peter Vandamme, Jens Walter, Koichi Watanabe, Sander 10 Wuyts, Giovanna E. Felis, Michael G. Gänzle, Sarah Lebeer]. 11 The definitive peer reviewed, edited version of this article is published in International Journal of 12 Systematic and Evolutionary Microbiology, https://doi.org/10.1099/ijsem.0.004107 13 1Huazhong Agricultural University, State Key Laboratory of Agricultural Microbiology, Hubei Key 14 Laboratory of Agricultural Bioinformatics, Wuhan, Hubei, P.R. China. 15 2Research Group Environmental Ecology and Applied Microbiology, Department of Bioscience 16 Engineering, University of Antwerp, Antwerp, Belgium 17 3 Dept. of Biotechnology, University of Verona, Verona, Italy 18 4 Max Rubner‐Institut, Department of Microbiology and Biotechnology, Kiel, Germany 19 5 School of Microbiology & APC Microbiome Ireland, University College Cork, Co. Cork, Ireland 20 6 University of Bologna, Dept. of Agricultural and Food Sciences, Bologna, Italy 21 7 Research Group of Industrial Microbiology and Food Biotechnology (IMDO), Vrije Universiteit 22 Brussel, Brussels, Belgium 23 8 Laboratory of Microbiology, Department of Biochemistry and Microbiology, Ghent University, Ghent, 24 Belgium 25 9 Department of Agricultural, Food & Nutritional Science, University of Alberta, Edmonton, Canada 26 10 Department of Biological Sciences, University of Alberta, Edmonton, Canada 27 11 National Taiwan University, Dept. -
Fiber-Associated Spirochetes Are Major Agents of Hemicellulose Degradation in the Hindgut of Wood-Feeding Higher Termites
Fiber-associated spirochetes are major agents of hemicellulose degradation in the hindgut of wood-feeding higher termites Gaku Tokudaa,b,1, Aram Mikaelyanc,d, Chiho Fukuia, Yu Matsuuraa, Hirofumi Watanabee, Masahiro Fujishimaf, and Andreas Brunec aTropical Biosphere Research Center, Center of Molecular Biosciences, University of the Ryukyus, Nishihara, 903-0213 Okinawa, Japan; bGraduate School of Engineering and Science, University of the Ryukyus, Nishihara, 903-0213 Okinawa, Japan; cResearch Group Insect Gut Microbiology and Symbiosis, Max Planck Institute for Terrestrial Microbiology, 35043 Marburg, Germany; dDepartment of Entomology and Plant Pathology, North Carolina State University, Raleigh, NC 27607; eBiomolecular Mimetics Research Unit, Institute of Agrobiological Sciences, National Agriculture and Food Research Organization, Tsukuba, 305-8634 Ibaraki, Japan; and fDepartment of Sciences, Graduate School of Sciences and Technology for Innovation, Yamaguchi University, Yoshida 1677-1, 753-8512 Yamaguchi, Japan Edited by Nancy A. Moran, University of Texas at Austin, Austin, TX, and approved November 5, 2018 (received for review June 25, 2018) Symbiotic digestion of lignocellulose in wood-feeding higher digestion in the hindgut of higher termites must be attributed to termites (family Termitidae) is a two-step process that involves their entirely prokaryotic microbial community (5). endogenous host cellulases secreted in the midgut and a dense The gut microbiota of higher termites comprises more than bacterial community in the hindgut compartment. The genomes of 1,000 bacterial phylotypes, which are organized into distinc- the bacterial gut microbiota encode diverse cellulolytic and hemi- tive communities colonizing the microhabitats provided by the cellulolytic enzymes, but the contributions of host and bacterial compartmentalized intestine, including the highly differentiated symbionts to lignocellulose degradation remain ambiguous. -
Lactococcus Lactis Cholangitis and Bacteremia Identified by MALDI-TOF Mass Spectrometry
J Infect Chemother xxx (2018) 1e6 Contents lists available at ScienceDirect Journal of Infection and Chemotherapy journal homepage: http://www.elsevier.com/locate/jic Case Report Lactococcus lactis cholangitis and bacteremia identified by MALDI-TOF mass spectrometry: A case report and review of the literature on Lactococcus lactis infection* * Akihiko Shimizu a, , Ryota Hase a, b, Daisuke Suzuki a, Akihiro Toguchi c, Yoshihito Otsuka c, Nobuto Hirata d, Naoto Hosokawa a a Department of Infectious Diseases, Kameda Medical Center, 929 Higashicho, Kamogawa, Chiba, 2968602, Japan b Department of Infectious Diseases, Japanese Red Cross Narita Hospital, 90-1 Iidacho, Narita, Chiba, 2868523, Japan c Department of Laboratory Medicine, Kameda Medical Center, 929 Higashicho, Kamogawa, Chiba, 2968602, Japan d Department of Gastroenterology, Kameda Medical Center, 929 Higashicho, Kamogawa, Chiba, 2968602, Japan article info abstract Article history: Lactococcus lactis is a rare causative organism in humans. Cases of L. lactis infection have only rarely been Received 22 March 2018 reported. However, because it is often difficult to identify by conventional commercially available Received in revised form methods, its incidence may be underestimated. We herein report the case of a 70-year-old man with 30 June 2018 cholangiocarcinoma who developed L. lactis cholangitis and review previously reported cases of L. lactis Accepted 17 July 2018 infection. Our case was confirmed by matrix-assisted desorption/ionization time-of-flight mass spec- Available online xxx trometry (MALDI-TOF MS). This case shows L. lactis is a potential causative pathogen of cholangitis and that MALDI-TOF MS can be useful for the rapid and accurate identification of L. -
Table S5. Components of the Probiotics in Each Included Clinical and Preclinical Literature
Electronic Supplementary Material (ESI) for Food & Function. This journal is © The Royal Society of Chemistry 2021 Table S5. Components of the probiotics in each included clinical and preclinical literature. Study Type of strains Randomized controlled trials Ebrahim Kouchaki Lactobacillus acidophilus, Lactobacillus casei, Bifidobacterium bifidum and Lactobacillus (2017) fermentum Mahmoud Salami Bifidobacterium infantis, Bifidobacterium lactis, Lactobacillus reuteri, Lactobacillus casei, (2019) Lactobacillus plantarum and Lactobacillus fermentum Mehran Bacillus subtilis PXN 21, Bifidobacterium bifidum PXN 23, Bifidobacterium breve PXN 25, Rahimlou(2020) Bifidobacterium infantis PXN 27, Bifidobacterium longum PXN 30, Lactobacillus acidophilus PXN 35, Lactobacillus delbrueckii ssp. bulgaricus PXN 39, Lactobacillus casei PXN 37, Lactobacillus plantarum PXN 47, Lactobacillus rhamnosus PXN 54, Lactobacillus helveticus PXN 45, Lactobacillus salivarius PXN 57, Lactococcus lactis ssp. lactis PXN 63, Streptococcus thermophilus PXN 66 Preclinical studies Kobayashi et al Lactobacillus casei strain Shirota, Bifidobacterium breve strain Yakult (2009) Lavasani et al Lactobacillus paracasei, DSM 13434; Lactobacillus plantarum, DSM 15312 (HEAL9); (2010) Lactobacillus plantarum, DSM 15313 (HEAL19); Lactobacillus paracasei, PCC (Probi Culture Collection) 101 and Lactobacillus delbrueckii, subsp. bulgaricus, DSM 20081 Ochoa-Repáraz et al Bacteroides fragilis (2010) Takata et al Pediococcus acidilactici R037 (2011) Kobayashi et al Lactobacillus casei strain -
Irritable Bowel Syndrome and Probiotics: from Rationale to Clinical Use Elena F
Irritable bowel syndrome and probiotics: from rationale to clinical use Elena F. Verdu and Stephen M. Collins Purpose of review Introduction Few therapies are of proven efficacy in irritable bowel In this review we discuss the gut-driven pathophysiologic syndrome. Thus, there is great interest in the development pathways involved in gut dysfunction and symptom gen- of a natural therapy that can be both safe and effective. An eration in irritable bowel syndrome (IBS), including immune understanding that probiotics are heterogeneous, with activation, dysmotility, altered mucosal barrier function, multiple targets and mechanisms of action, is fundamental and visceral perception. This allows us to logically review to the development of clinical trials. the possible targets of probiotic therapy in IBS. Finally, we Recent findings evaluate the relevant clinical trials published to date on A bidirectional model for the pathogenesis of irritable bowel probiotics and IBS. syndrome is proposed in which gut-driven and brain-driven mechanisms contribute to the genesis of gut dysfunction and symptoms. In-vitro and animal studies have generated Gut dysfunction in irritable bowel syndrome most of the mechanistic rationale for the use of probiotics The current goal of treatment in IBS is to alleviate symp- in functional bowel disorders. A MEDLINE search of toms and improve quality of life. The gut-driven patho- publications from 1989 to date revealed only eight physiologic mechanisms believed to be involved in the placebo-controlled clinical trials on the subject of origin or maintenance of IBS symptoms include intestinal probiotics and irritable bowel syndrome. All these studies infection and immune activation, dysmotility, abnormal • suffer from methodologic problems. -
The Effects of Nisin-Producing Lactococcus Lactis Strain Used As Probiotic on Gilthead Sea Bream (Sparus Aurata) Growth, Gut Microbiota, and Transcriptional Response
fmars-08-659519 April 9, 2021 Time: 13:57 # 1 ORIGINAL RESEARCH published: 12 April 2021 doi: 10.3389/fmars.2021.659519 The Effects of Nisin-Producing Lactococcus lactis Strain Used as Probiotic on Gilthead Sea Bream (Sparus aurata) Growth, Gut Microbiota, and Transcriptional Response Federico Moroni1†, Fernando Naya-Català2†, M. Carla Piazzon3, Simona Rimoldi1, Edited by: Josep Calduch-Giner2, Alberto Giardini4, Inés Martínez5, Fabio Brambilla6, Fotini Kokou, 2 1 Wageningen University and Research, Jaume Pérez-Sánchez and Genciana Terova * Netherlands 1 Department of Biotechnology and Life Sciences, University of Insubria, Varese, Italy, 2 Nutrigenomics and Fish Growth Reviewed by: Endocrinology, Institute of Aquaculture Torre de la Sal (IATS-CSIC), Castellón, Spain, 3 Fish Pathology, Institute Carlo C. Lazado, of Aquaculture Torre de la Sal (IATS-CSIC), Castellón, Spain, 4 Centro Sperimentale del Latte S.r.l., Zelo Buon Persico, Italy, Norwegian Institute of Food, Fisheries 5 Sacco S.r.l., Cadorago, Italy, 6 VRM S.r.l. Naturalleva, Cologna Veneta, Italy and Aquaculture Research (Nofima), Norway Yun-Zhang Sun, The present research tested the effects of dietary nisin-producing Lactococcus lactis Jimei University, China on growth performance, feed utilization, intestinal morphology, transcriptional response, *Correspondence: and microbiota in gilthead sea bream (Sparus aurata). A feeding trial was conducted Genciana Terova [email protected] with fish weighting 70–90 g. Fish were tagged with passive, integrated transponders †These authors have contributed and distributed in nine 500 L tanks with 40 fish each. Fish were fed for 12 weeks with equally to this work either a control (diet A) or experimental diets (diets B and C) in triplicate (3 tanks/diet). -
Microbiological and Metagenomic Characterization of a Retail Delicatessen Galotyri-Like Fresh Acid-Curd Cheese Product
fermentation Article Microbiological and Metagenomic Characterization of a Retail Delicatessen Galotyri-Like Fresh Acid-Curd Cheese Product John Samelis 1,* , Agapi I. Doulgeraki 2,* , Vasiliki Bikouli 2, Dimitrios Pappas 3 and Athanasia Kakouri 1 1 Dairy Research Department, Hellenic Agricultural Organization ‘DIMITRA’, Katsikas, 45221 Ioannina, Greece; [email protected] 2 Hellenic Agricultural Organization ‘DIMITRA’, Institute of Technology of Agricultural Products, 14123 Lycovrissi, Greece; [email protected] 3 Skarfi EPE—Pappas Bros Traditional Dairy, 48200 Filippiada, Greece; [email protected] * Correspondence: [email protected] (J.S.); [email protected] (A.I.D.); Tel.: +30-2651094789 (J.S.); +30-2102845940 (A.I.D.) Abstract: This study evaluated the microbial quality, safety, and ecology of a retail delicatessen Galotyri-like fresh acid-curd cheese traditionally produced by mixing fresh natural Greek yogurt with ‘Myzithrenio’, a naturally fermented and ripened whey cheese variety. Five retail cheese batches (mean pH 4.1) were analyzed for total and selective microbial counts, and 150 presumptive isolates of lactic acid bacteria (LAB) were characterized biochemically. Additionally, the most and the least diversified batches were subjected to a culture-independent 16S rRNA gene sequencing analysis. LAB prevailed in all cheeses followed by yeasts. Enterobacteria, pseudomonads, and staphylococci were present as <100 viable cells/g of cheese. The yogurt starters Streptococcus thermophilus and Lactobacillus delbrueckii were the most abundant LAB isolates, followed by nonstarter strains of Lactiplantibacillus, Lacticaseibacillus, Enterococcus faecium, E. faecalis, and Leuconostoc mesenteroides, Citation: Samelis, J.; Doulgeraki, A.I.; whose isolation frequency was batch-dependent. Lactococcus lactis isolates were sporadic, except Bikouli, V.; Pappas, D.; Kakouri, A. Microbiological and Metagenomic for one cheese batch. -
Obesity-Associated Gut Microbiota Is Enriched in Lactobacillus Reuteri and Depleted in Bifidobacterium Animalis and Methanobrevibacter Smithii
International Journal of Obesity (2012) 36, 817–825 & 2012 Macmillan Publishers Limited All rights reserved 0307-0565/12 www.nature.com/ijo ORIGINAL ARTICLE Obesity-associated gut microbiota is enriched in Lactobacillus reuteri and depleted in Bifidobacterium animalis and Methanobrevibacter smithii M Million1, M Maraninchi2, M Henry1, F Armougom1, H Richet1, P Carrieri3,4,5, R Valero2,DRaccah6, B Vialettes2 and D Raoult1 1URMITE -CNRS UMR 6236 IRD 198, IFR 48, Faculte´ de Me´decine, Universite´ de la Me´diterrane´e, Marseille, France; 2Service de Nutrition, Maladies Me´taboliques et Endocrinologie, UMR-INRA U1260, CHU de la Timone, Marseille, France; 3INSERM, U912(SE4S), Marseille, France; 4Universite´ Aix Marseille, IRD, UMR-S912, Marseille, France; 5ORS PACA, Observatoire Re´gional de la Sante´ Provence Alpes Coˆte d’Azur, Marseille, France and 6Service de Nutrition et Diabe´tologie, CHU Sainte Marguerite, Marseille, France Background: Obesity is associated with increased health risk and has been associated with alterations in bacterial gut microbiota, with mainly a reduction in Bacteroidetes, but few data exist at the genus and species level. It has been reported that the Lactobacillus and Bifidobacterium genus representatives may have a critical role in weight regulation as an anti-obesity effect in experimental models and humans, or as a growth-promoter effect in agriculture depending on the strains. Objectives and methods: To confirm reported gut alterations and test whether Lactobacillus or Bifidobacterium species found in the human gut are associated with obesity or lean status, we analyzed the stools of 68 obese and 47 controls targeting Firmicutes, Bacteroidetes, Methanobrevibacter smithii, Lactococcus lactis, Bifidobacterium animalis and seven species of Lactobacillus by quantitative PCR (qPCR) and culture on a Lactobacillus-selective medium. -
From Streptococcus Lactis to Lactococcus Lactis: a Qualitative and Quantitative Analysis of the Scope of Research Undertaken Around a Microbial Concept
JSCIRES RESEARCH ARTICLE From Streptococcus lactis to Lactococcus lactis: A qualitative and quantitative analysis of the scope of research undertaken around a microbial concept Yann Demarigny*, Virginie Soldat1, Laetitia Gemelas BioDyMIA: Bioengineering and Microbial Dynamic at Food Interfaces (Associated team n°3733: University of Lyon 1 ‑ ISARA Lyon), Isara‑Lyon, Agrapole ‑ 23 rue Jean Baldassini, F ‑ 69364 Lyon Cedex 07, 1Ressource Center, Isara‑Lyon, Agrapole ‑ 23 rue Jean Baldassini, F ‑ 69364 Lyon Cedex 07, France ABSTRACT The lactic acid bacterium Lactococcus lactis, formerly named Streptococcus lactis, has been known and used for many years, even before its re-affiliation in 1985. The number of published papers featuring one of the two names, either in the title or in the key words, currently stands at more than 2,900. From 1945 to 2014, a bibliometric analysis of the evolution of this bacterium allowed us to identify three phases we have called 1, the “exploratory period” (or the “US period” if we refer to the origin of the labs most frequently involved in the publications), 2, the “explanatory period” (dominated by French and Dutch labs) and 3, the “enlargement period” (or the “Asian period”). We noticed in particular that the evolution of research on this bacterium did not depend on its affiliation but rather on the accessibility to powerful tools and information. Trends and competition between labs were certainly driving forces in the knowledge acquired on Lactococcus lactis. We can expect to see more research on this bacterial concept, expanding to new fields, with the arrival of new labs in countries such as China and India.